Skip to content

H.R. 7902 · 119th Congress (2025–2027)

Safeguarding Women from Chemical Abortion Act

To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 7902’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Diana Harshbarger (R-TN-1)
Cosponsors
11 cosponsors

0 original · 11 later

11 R

  1. Rep. John W. Rose (R-TN-6)· Later · Mar 18, 2026
  2. Rep. Mark Alford (R-MO-4)· Later · Mar 20, 2026
  3. Rep. Neal P. Dunn (R-FL-2)· Later · Mar 20, 2026
  4. Rep. Sheri Biggs (R-SC-3)· Later · Mar 24, 2026
  5. Rep. Tracey Mann (R-KS-1)· Later · Mar 24, 2026
  6. Rep. Christopher H. Smith (R-NJ-4)· Later · Apr 22, 2026
  7. Rep. Mary E. Miller (R-IL-15)· Later · May 14, 2026
  8. Rep. W. Gregory Steube (R-FL-17)· Later · May 21, 2026
  9. Rep. Ralph Norman (R-SC-5)· Later · Aug 31, 2026
  10. Rep. Roger Williams (R-TX-25)· Later · Aug 31, 2026
  11. Rep. Andrew S. Clyde (R-GA-9)· Later · Sep 1, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 12, 2026
  2. HouseJudiciaryReferred Mar 12, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Safeguarding Women from Chemical Abortion Act

    Display title, Short title · Introduced in House

  2. To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

    Official title · Introduced in House